Business and other management consultancy activities
PHARMAPATENT AS
Revenue 2025
NOK 174,000
Operating profit
NOK 19,000
Equity
NOK 2.6m
Incorporated
2008
Share capital
NOK 100,000
Key figures · 2025
Current ratio
17.22
Equity ratio
96.6%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 10.8% | |
| Net margin (%%) | -251.4% | |
| Return on assets (%%) | 0.7% | |
| Likviditet | ||
| Current ratio | 17.22 | |
| Working capital | 1.5m | |
| Soliditet | ||
| Equity ratio (%%) | 96.6% | |
| Debt-to-equity ratio | 0.04 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.